Detailed Information
Cited 3 time in 
Cited 4 time in 
Cited 4 time in
Metadata Downloads
Improving Participation in Clinical Trials of Novel Therapies: Going Back to Basics
- Issue Date
- Aug-2014
- Publisher
- W. B. Saunders Co., Ltd.
- Keywords
- Systemic lupus erythematosus; Randomized clinical trials; Enrollment; Retention
- Citation
- Rheumatic Disease Clinics of North America, v.40, no.3, pp 553 - 559
- Pages
- 7
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- Rheumatic Disease Clinics of North America
- Volume
- 40
- Number
- 3
- Start Page
- 553
- End Page
- 559
- ISSN
- 0889-857X
1558-3163
- Abstract
- Clinical trials in many diseases are experiencing'more difficulties in achieving sufficient or timely enrollment of participants; anecdotal reports from trials of novel therapies for systemic lupus erythematosus (SLE) seem to be facing the same challenges. General factors associated with this trend include the growth of the contract research industry, increasing oversight, and high-profile accounts of scientific misconduct and fraud in research. Complicated protocols that increase participant burden, overly restrictive entry criteria, the fear of an SLE flare may also affect enrollment in SLE trials.
- Files in This Item
- Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Choi, Chan Bum
- 서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)